获取途径

作者

Wu, Lei Yang, Lan-Ju Meng, Xiao-Yan Wang, Lan-Hua Zhou, Yan-Hong Liu, Tao Han, Qian-Feng Zhang, De-Yong Yao, Heng-Chen

作者单位

Department of Cardiology, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng 252000, PR China Department of Echocardiography, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Shandong Province, Liaocheng 252000, PR China

刊名

International Journal of Cardiology

年份

2016

卷号

Vol.204

页码

152-153

ISSN

0031-6873

关键词

Hyperuricemia Percutaneous coronary intervention Outcome

摘要

Uric acid is the end product of purine catabolism. Lot of previous studies have found that hyperuricemia (HU) as a risk factor for cardiovascular diseases such as atrial fibrillation and coronary artery disease [1,2]. Also, HU is a predictor of adverse prognosis in different cardiocerebral diseases, such as acute ST segment elevation myocardial infarction, congestive heart failure and acute stroke. However, the predictive value of HU in the prognosis in patients undergoing percutaneous coronary ...更多

Uric acid is the end product of purine catabolism. Lot of previous studies have found that hyperuricemia (HU) as a risk factor for cardiovascular diseases such as atrial fibrillation and coronary artery disease [1,2]. Also, HU is a predictor of adverse prognosis in different cardiocerebral diseases, such as acute ST segment elevation myocardial infarction, congestive heart failure and acute stroke. However, the predictive value of HU in the prognosis in patients undergoing percutaneous coronary intervention (PCI) is less known.收起

学科

【SCI学科】CARDIAC & CARDIOVASCULAR SYSTEMS 【ESI学科】CLINICAL MEDICINE

影响因子

2016年:6.189;2015年:4.638;2014年:4.036;2013年:6.175;2012年:5.509

文献类型

期刊

浏览量

2